Cargando…

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Detalles Bibliográficos
Autores principales:	Peters, Godefridus J., Giovannetti, Elisa, Honeywell, Richard J., Ciccolini, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533421/ https://www.ncbi.nlm.nih.gov/pubmed/30866103 http://dx.doi.org/10.1111/bcp.13921

Ejemplares similares

Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study
por: Tibaldi, Carmelo, et al.
Publicado: (2018)

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective
por: Ciccolini, Joseph, et al.
Publicado: (2016)

FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients
por: Serdjebi, Cindy, et al.
Publicado: (2015)

Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by upregulating cytidine deaminase
por: Amit, Moran, et al.
Publicado: (2013)

Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
por: Narvaiza, Iñigo, et al.
Publicado: (2009)

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism
por: Maring, Jan Gerard, et al.
Publicado: (2010)

hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients
por: Meijer, Laura L., et al.
Publicado: (2016)

Fungal mycobiome-mediated immune response: a non-negligible promoter in pancreatic oncogenesis and chemoresistance
por: Jiang, Yaling, et al.
Publicado: (2023)

m(6)A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer
por: Zhang, Congjun, et al.
Publicado: (2021)

The fallout from crossing paths with cellular cytidine deaminases
por: Wain-Hobson, Simon, et al.
Publicado: (2009)

Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases
por: Koito, Atsushi, et al.
Publicado: (2013)

A putative antiviral role of plant cytidine deaminases
por: Martín, Susana, et al.
Publicado: (2017)

A new technique for the analysis of metabolic pathways of cytidine analogues and cytidine deaminase activities in cells
por: Ligasová, Anna, et al.
Publicado: (2023)

Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA
por: Caval, Vincent, et al.
Publicado: (2019)

The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2
por: Sarkisjan, Dzjemma, et al.
Publicado: (2016)

Human APOBEC1 cytidine deaminase edits HBV DNA
por: Gonzalez, Minerva Cervantes, et al.
Publicado: (2009)

Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers
por: Park, Seok-Rae
Publicado: (2012)

Expanding C–T base editing toolkit with diversified cytidine deaminases
por: Cheng, Tian-Lin, et al.
Publicado: (2019)

Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar-Labarchède, Géraldine, et al.
Publicado: (2022)

The APOBEC3B cytidine deaminase is an adenovirus restriction factor
por: Lejeune, Noémie, et al.
Publicado: (2023)

Activation induced cytidine deaminase: An old friend with new faces
por: Çakan, Elif, et al.
Publicado: (2022)

Synthesis of a bifunctional cytidine derivative and its conjugation to RNA for in vitro selection of a cytidine deaminase ribozyme
por: Rublack, Nico, et al.
Publicado: (2014)

APOBEC3A is a prominent cytidine deaminase in breast cancer
por: Cortez, Luis M., et al.
Publicado: (2019)

Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
por: Watashi, Koichi, et al.
Publicado: (2013)

The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections
por: Vieira, Valdimara C., et al.
Publicado: (2013)

Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine
por: Adema, Auke D, et al.
Publicado: (2014)

Maize haplotype with a helitron-amplified cytidine deaminase gene copy
por: Xu, Jian-Hong, et al.
Publicado: (2006)

Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis
por: Sun, Yonglian, et al.
Publicado: (2013)

Activation-Induced Cytidine Deaminase Does Not Impact Murine Meiotic Recombination
por: Cortesao, Catarina S., et al.
Publicado: (2013)

Characterization of immunoglobulin mutations in humans with activation-induced cytidine deaminase deficiency
por: Longo, Nancy S, et al.
Publicado: (2007)

LINE-1 Retroelements Complexed and Inhibited by Activation Induced Cytidine Deaminase
por: Metzner, Mirjam, et al.
Publicado: (2012)

Epigenetic Function of Activation-Induced Cytidine Deaminase and Its Link to Lymphomagenesis
por: Dominguez, Pilar M., et al.
Publicado: (2014)

Phosphorylation promotes activation-induced cytidine deaminase activity at the Myc oncogene
por: Mu, Yunxiang, et al.
Publicado: (2017)

Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase
por: Ma, Yunqing, et al.
Publicado: (2020)

APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein
por: Wang, Shui-Mei, et al.
Publicado: (2009)

Lack of activation-induced cytidine deaminase expression in in situ follicular neoplasia
por: Goyal, Tanu, et al.
Publicado: (2021)

Efficient Deamination of 5-Methylcytidine and 5-Substituted Cytidine Residues in DNA by Human APOBEC3A Cytidine Deaminase
por: Suspène, Rodolphe, et al.
Publicado: (2013)

Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid Leukemia
por: Medina-Sanson, Aurora, et al.
Publicado: (2015)

The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromes
por: Murakami, Yuichi, et al.
Publicado: (2019)

Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
por: Comandatore, Annalisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3cra0k8tkab068hqhcv1squf3g